Aliskiren for Geriatric Lowering of Systolic Hypertension: a randomized controlled trial
Authors:
Open Access
- 24 December 2009
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 24 (9) , 600-608
Abstract
Efficacy and safety of the direct renin inhibitor aliskiren was compared with ramipril for treatment of essential systolic hypertension in elderly patients. A 36-week, randomized, double-blind, parallel-group, active-controlled, optional-titration study was performed in 901 patients (aliskiren, n=457; ramipril, n=444) 65 years of age with systolic blood pressure (SBP) 140 mm Hg. Aliskiren 150–300 mg per day or ramipril 5–10 mg per day for was administered for 12 weeks with optional add-on therapy of hydrochlorothiazide (12.5–25 mg per day) at week 12 and amlodipine (5–10 mg per day) at week 22. The primary end point was non-inferiority of aliskiren vs ramipril monotherapy for change from baseline in mean sitting SBP (msSBP) at week 12. Decreases from baseline msSBP and mean sitting diastolic BP with aliskiren monotherapy (−14.0 and −5.1 mm Hg, respectively) were non-inferior (PP=0.02, PPP=0.01 and 0.048, respectively). Tolerability was similar, but more patients receiving ramipril reported cough (P<0.001). In elderly patients with systolic hypertension, aliskiren proved to be more effective and better overall anti-hypertensive therapy compared to ramipril.Keywords
This publication has 34 references indexed in Scilit:
- Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor AliskirenCirculation, 2009
- AliskirenCirculation, 2008
- Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment IntensificationJournal of General Internal Medicine, 2008
- Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trialJournal Of Hypertension, 2008
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Direct Renin Inhibition With Aliskiren in Obese Patients With Arterial HypertensionHypertension, 2007
- Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004Hypertension, 2007
- Recommendations for Blood Pressure Measurement in Humans and Experimental AnimalsHypertension, 2005
- Management of Hypertension in the Very Elderly PatientHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003